APA (7th ed.) Citation

Albayda, J., Pinal‐Fernandez, I., Huang, W., Parks, C., Paik, J., Casciola‐Rosen, L., . . . Mammen, A. L. (2017). Antinuclear Matrix Protein 2 Autoantibodies and Edema, Muscle Disease, and Malignancy Risk in Dermatomyositis Patients. Arthritis care & research (2010), 69(11), 1771-1776. https://doi.org/10.1002/acr.23188

Chicago Style (17th ed.) Citation

Albayda, Jemima, et al. "Antinuclear Matrix Protein 2 Autoantibodies and Edema, Muscle Disease, and Malignancy Risk in Dermatomyositis Patients." Arthritis Care & Research (2010) 69, no. 11 (2017): 1771-1776. https://doi.org/10.1002/acr.23188.

MLA (9th ed.) Citation

Albayda, Jemima, et al. "Antinuclear Matrix Protein 2 Autoantibodies and Edema, Muscle Disease, and Malignancy Risk in Dermatomyositis Patients." Arthritis Care & Research (2010), vol. 69, no. 11, 2017, pp. 1771-1776, https://doi.org/10.1002/acr.23188.